Tag Archives: Bruce C Stouch

Characteristics of CFS/ME sub-group who respond to Rintatolimod (Ampligen)

Research abstract: Background: Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a debilitating disease of unknown pathogenesis consisting of  a variety of flu-like symptoms including severe fatigue. Initial analysis of the use of rintatolimod (Poly I: Poly C12U), a selective TLR3 agonist, … Continue reading

Posted in News | Tagged , , , , , , , , , , , , , , | Comments Off on Characteristics of CFS/ME sub-group who respond to Rintatolimod (Ampligen)